Astellas eyes Japan approval for bladder control drug

Japan's Astellas Pharma said on Friday it was seeking approval from Japanese health authorities for a bladder control drug.

The company said it was seeking approval for the drug, known as mirabegron or YM178, to treat urinary frequency and urge urinary incontinence associated with an overactive bladder.

($1=90.92 Yen)

(Reporting by Taiga Uranaka)